Published in J Natl Cancer Inst on April 01, 1967
SV40 induces mesotheliomas in hamsters. Am J Pathol (1993) 1.64
Prolonged administration of antithymocyte serum in mice. II. Histopathological investigation. Clin Exp Immunol (1971) 0.94
Tumour development following immunosuppression. Proc R Soc Med (1970) 0.89
The structure of tumours derived from mouse cells after "spontaneous" transformation in vitro. Br J Cancer (1970) 0.88
Immune responses to virus-induced tumours. Proc R Soc Med (1969) 0.75
An examination of the cytotoxic effects of silica on macrophages. J Exp Med (1966) 8.42
Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet (1971) 7.98
Role of contractile microfilaments in macrophage movement and endocytosis. Nat New Biol (1971) 4.82
Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia. J Exp Med (1989) 4.66
Macrophages and age-dependent resistance to Herpes simplex virus in mice. J Immunol (1970) 4.15
Membrane fusion. Biochim Biophys Acta (1973) 3.75
Selective effects of anti-macrophage serum, silica and anti-lymphocyte serum on pathogenesis of herpes virus infection of young adult mice. J Immunol (1970) 3.49
Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA. Proc Natl Acad Sci U S A (1988) 3.34
M-antiglobulins (rheumatoid-factor-like globulins) and other gamma-globulins in relation to tropical parasitic infections. Lancet (1966) 3.31
Requirement of thymus-dependent lymphocytes for potentiation by adjuvants of antibody formation. Nature (1971) 3.30
Identification of human mononuclear leucocyte populations by esterase staining. Clin Exp Immunol (1977) 3.12
Protection of mice against Babesia and Plasmodium with BCG. Nature (1976) 3.01
Relationship between muscle fiber types and sizes and muscle architectural properties in the mouse hindlimb. J Morphol (1994) 2.99
Asbestos induces selective release of lysosomal enzymes from mononuclear phagocytes. Nature (1974) 2.86
Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection. J Exp Med (1977) 2.84
Extensive prolongation of rabbit kidney allograft survival after short-term cyclosporin-A treatment. Lancet (1978) 2.80
Changes in cellular enzyme levels and extracellular release of lysosomal acid hydrolases in macrophages exposed to group A streptococcal cell wall substance. J Exp Med (1974) 2.72
Effects of antilymphocyte serum on virus oncogenesis. Proc Soc Exp Biol Med (1968) 2.63
Effects of activated complement components on enzyme secretion by macrophages. Immunology (1976) 2.63
Babesia microti and Plasmodium berghei yoelii infections in nude mice. Nature (1974) 2.55
Antibody responses to antigenic determinants of influenza virus hemagglutinin. I. Thymus dependence of antibody formation and thymus independence of immunological memory. J Exp Med (1974) 2.54
Morphologic, cytogenetic and virologic studies in vitro of a malignant lymphoma from an African child. Int J Cancer (1966) 2.51
An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity. J Immunol Methods (1986) 2.50
Potentiation by silica of the growth of Mycobacterium tuberculosis in macrophage cultures. Br J Exp Pathol (1968) 2.48
Interactions of antibodies, complement components and various cell types in immunity against viruses and pyogenic bacteria. Transplant Rev (1974) 2.45
Inhibition of the primary in vitro antibody response by interferon preparations. J Immunol (1975) 2.35
Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection. J Immunol (1976) 2.34
Physico-chemical properties of silica in relation to its toxicity. Nature (1966) 2.32
The pathogenesis of autoimmunity in New Zealand mice, I. Induction of antinucleic acid antibodies by polyinosinic-polycytidylic acid. Proc Natl Acad Sci U S A (1969) 2.31
Lymphocytes binding human thyroglobulin in healthy people and its relevance to tolerance for autoantigens. Lancet (1973) 2.28
Protection of mice against Babesia spp. and Plasmodium spp. with killed Corynebacterium parvum. Parasitology (1977) 2.28
Antibody responses to antigenic determinants of influenza virus hemagglutinin. II. Original antigenic sin: a bone marrow-derived lymphocyte memory phenomenon modulated by thymus-derived lymphocytes. J Exp Med (1974) 2.25
Murine sarcoma virus (Harvey): characteristics of focus formation in mouse embryo cell cultures, and virus production by hamster tumor cells. Int J Cancer (1968) 2.24
Mechanisms by which activated macrophages inhibit lymphocyte responses. Immunol Rev (1978) 2.24
Nature of the effector cells responsible for antibody-dependent cell-mediated killing of Cryptococcus neoformans. Infect Immun (1976) 2.16
Heterophile antibodies, M-antiglobulins and immunoglobulins in experimental trypanosomiasis. Clin Exp Immunol (1969) 2.16
A modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates. J Infect Dis (1975) 2.14
The effect of interferon on SV-40 T antigen production in SV-40-transformed cells. Virology (1967) 2.13
The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. J Clin Invest (1990) 2.08
Relative ability of mitogens to stimulate production of interferon by lymphoid cells and to induce suppression of the in vitro immune response. Proc Soc Exp Biol Med (1977) 2.07
A role of macrophages in the stimulation of immune responses by adjuvants. J Immunol (1969) 2.06
Herpetic keratoconjunctivitis: therapy with synthetic double-stranded RNA. Science (1968) 2.02
Role of contractile microfilaments in the release of histamine from mast cells. Nature (1972) 1.99
Role of lysosomes and of cell membranes in photosensitization. Nature (1966) 1.91
Use of cyclosporin A in allogeneic bone marrow transplantation in the rat. Nature (1979) 1.90
The inhibition of phagocytosis and facilitation of exocytosis in rabbit polymorphonuclear leukocytes by cytochalasin B. Lab Invest (1973) 1.89
The role of cell-mediated immune responses in resistance to malaria, with special reference to oxidant stress. Annu Rev Immunol (1983) 1.88
Antibacterial antibodies in rectal and colonic mucosa in ulcerative colitis. Lancet (1971) 1.88
Ability of activated complement components to induce lysosomal enzyme release from macrophages. Nature (1976) 1.85
Mineral fibers: chemical, physicochemical, and biological properties. Adv Pharmacol Chemother (1975) 1.83
Dual role of tumor necrosis factor-alpha in angiogenesis. Am J Pathol (1992) 1.82
Zymosan-induced arthritis: a model of chronic proliferative arthritis following activation of the alternative pathway of complement. Arthritis Rheum (1977) 1.82
Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation. Immunology (1977) 1.82
Tissue thromboplastin activity of isolated human monocytes. Thromb Haemost (1978) 1.81
Improved assays for a variety of interferons. 1. Proc Soc Exp Biol Med (1972) 1.79
Mode of action of adjuvants: effects on antibody responses to macrophage-associated bovine serum albumin. J Immunol (1970) 1.79
Immune responses in mice with murine leprosy. Clin Exp Immunol (1970) 1.79
High interferon producing line of transformed murine cells. J Gen Virol (1972) 1.79
Role of interferon during viremia. II. Protective action of circulating interferon. J Immunol (1966) 1.76
Genetic factors in resistance against virus infections. Arch Gesamte Virusforsch (1965) 1.74
Role of macrophages and antibody in resistance of mice against yellow fever virus. J Immunol (1971) 1.71
Temperature-sensitive mutants of influenza virus. IV. Induction of interferon in the nasopharynx by wild-type and a temperature-sensitive recombinant virus. J Infect Dis (1973) 1.70
The role of thymus-dependent immunity in Mycoplasma pulmonis infections of mice. J Med Microbiol (1972) 1.69
Mechanisms of endocytosis and exocytosis. Symp Soc Exp Biol (1974) 1.69
The role of antibody and host cells in the resistance of mice against infection by coxsackie B-3 virus. J Gen Virol (1973) 1.68
Role of T lymphocytes in recovery from murine cytomegalovirus infection. Infect Immun (1977) 1.68
Unresponsiveness to self antigens. Lancet (1971) 1.67
Morphological transformation of mouse embryo cells in vitro by murine sarcoma virus (Harvey). Nature (1967) 1.67
Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion. Scand J Immunol (1991) 1.67
Immune complexes induce selective release of lysosomal hydrolases from macrophages. Nature (1974) 1.64
Virus plaque-reduction assay for interferon: microplaque and regular macroplaque reduction assays. Methods Enzymol (1981) 1.62
Interleukin-2 in rheumatoid arthritis: production of and response to interleukin-2 in rheumatoid synovial fluid, synovial tissue and peripheral blood. Clin Exp Immunol (1985) 1.61
The role of microfilaments and microtubules in cell movement, endocytosis and exocytosis. Ciba Found Symp (1973) 1.61
Monoclonal antibodies to human recombinant interleukin 1 (IL 1)beta: quantitation of IL 1 beta and inhibition of biological activity. J Immunol (1987) 1.61
Pathogenesis of the chronic inflammatory lesion induced by group A streptococcal cell walls. Lab Invest (1974) 1.60
The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect (2005) 1.60
Serum containing tumor necrosis factor is cytotoxic for the human malaria parasite Plasmodium falciparum. Infect Immun (1983) 1.60
Immunity and immunopathology in virus infections. Ann Inst Pasteur (Paris) (1972) 1.60
Participation of mononuclear phagocytes in chronic inflammatory diseases. J Reticuloendothel Soc (1974) 1.59
RS-61443--a new, potent immunosuppressive agent. Transplantation (1991) 1.57
On the role of mononuclear phagocytes in immunity against viruses. Prog Med Virol (1974) 1.55
Epidemiology of vertebral osteomyelitis (VO) in France: analysis of hospital-discharge data 2002-2003. Epidemiol Infect (2007) 1.54
The role of interferon in the inhibition of SV40 transformation of mouse cell line 3T3. Proc Natl Acad Sci U S A (1965) 1.52
General considerations of the interferon system. Tex Rep Biol Med (1977) 1.52
Role of mononuclear infiltrating cells in pathogenesis of hepatitis. Lancet (1978) 1.52
IFN-beta mediates coordinate expression of antigen-processing genes in RSV-infected pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol (2001) 1.49
Differences in susceptibility of various mouse strains to haemoprotozoan infections: possible correlation with natural killer activity. Parasite Immunol (1980) 1.48
European Sero-Epidemiology Network: standardisation of the assay results for pertussis. Vaccine (2003) 1.48
Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies. J Immunol Methods (1989) 1.48
The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network. Epidemiol Infect (2000) 1.48
Observations on thymectomy and carcinogenesis. Cancer Res (1967) 1.48
Correlation of persistent mouse hepatitis virus (MHV-3) infection with its effect on mouse macrophage cultures. Arch Virol (1976) 1.48
Kinetics of serum interferon response in mice after single and multiple injections of polyI-poly C. Proc Soc Exp Biol Med (1971) 1.47
Production of the complement cleavage product, C3a, by activated macrophages and its tumorolytic effects. Clin Exp Immunol (1978) 1.46
Immune complexes in mice infected neonatally with Moloney leukaemogenic and murine sarcoma viruses. Nature (1969) 1.46
A radical interpretation of immunity to malaria parasites. Lancet (1982) 1.46
Absence of a newly described cytochrome b from neutrophils of patients with chronic granulomatous disease. Lancet (1978) 1.45
Chromosome damage in human diploid cells following activation of lysosomal enzymes. Nature (1965) 1.45
Antioxidants inhibit the in vitro production of inflammatory cytokines in Crohn's disease and ulcerative colitis. Eur J Clin Invest (1998) 1.44
Neonatally induced allograft tolerance may be mediated by serum-borne factors. Nature (1971) 1.43